Dauwen Van der Staey Farma SRL
Dauwen Van der Staey Farma reported total assets of 313,136 € at the end of the 2025 financial year (annual accounts filed with the NBB on 31 Jul 2026).
The score of Dauwen Van der Staey Farma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +326 % Total assets +21 %
Accounts of the company itself (not consolidated).
The full file covers 6 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Dauwen Van der Staey Farma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Jul 2026
- Year ended 31 Dec 2024filed on 01 Jul 2025
- Year ended 31 Dec 2023filed on 11 Jul 2024
- Year ended 31 Dec 2022filed on 13 Jul 2023
- Year ended 31 Dec 2021filed on 23 Sep 2022
Dauwen Van der Staey Farma's financial analysis
- Solvency43.1%sector median: 55.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Dauwen Van der Staey Farma
Dauwen Van der Staey Farma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0744.759.169
- VAT number
- BE0744759169
- Peppol
- Registered · 0208:0744759169 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 05 Mar 2020
- Registered office
- 2460 Kasterlee
- Latest accounts
- 2025 · filed on 31 Jul 2026
- Activity
- Activities of holding companies (NACE 64210)
Dauwen Van der Staey Farma (SRL) has been based in Kasterlee since 2020, active in: activities of holding companies. For 2025, it reports a net profit of 37,989 € and equity of 134,946 €; its revenue is not published.
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Dauwen Van der Staey Farma
Companies in the same business, of comparable size and area, outside its group.
- "Pieter-Jan Van Durme" Activities of holding companies Lievegem · balance sheet 313,169 €
- Vafra Activities of holding companies Brakel · balance sheet 313,550 €
- DMVO Activities of holding companies Aalst · balance sheet 313,660 €
- GVO Service Activities of holding companies Sint-Gillis-Waas · balance sheet 312,560 €
- BC Industrial Management Services Activities of holding companies Merelbeke-Melle · balance sheet 313,779 €
- KEY4More Activities of holding companies Beringen · balance sheet 313,818 €
- Giwono Activities of holding companies Hamont-Achel · balance sheet 312,225 €
- HAM Holding Activities of holding companies Auderghem · balance sheet 311,886 €
Frequently asked questions about Dauwen Van der Staey Farma
What is the revenue of Dauwen Van der Staey Farma?
Dauwen Van der Staey Farma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Dauwen Van der Staey Farma?
In Belgium, the VAT number is the company number prefixed with BE: BE0744759169 for Dauwen Van der Staey Farma, if the company is VAT-registered. Its company number (CBE) is 0744.759.169.
Where is the registered office of Dauwen Van der Staey Farma?
According to the CBE register, the registered office of Dauwen Van der Staey Farma is in 2460 Kasterlee.
What is the equity of Dauwen Van der Staey Farma?
At the close of the 2025 financial year, the equity of Dauwen Van der Staey Farma amounts to 134,946 €, a solvency of 43.1% of total assets.
Who manages Dauwen Van der Staey Farma?
The register lists 1 active mandates at Dauwen Van der Staey Farma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Dauwen Van der Staey Farma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →